Pfizer/BioNTech and Moderna are seeking full approval for their Vaccines

Six months after receiving Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for COVID-19 vaccines, Pfizer/BioNTech and Moderna are planning to seek full approval for the preventative medications. 

Friday, May 7, 2021, Pfizer and BioNTech announced they initiated a rolling submission of a Biologics License Application (BLA) with the FDA for full approval of their mRNA vaccine in individuals 16 and older. This was the same demographic the vaccine was authorized for in December.  

StreetLoc is one of America’s fastest-growing Social Media companies. We do not employ woke kids in California to “police” your thoughts and put you in “jail”.
StreetLoc is designed for Family, Friends, Events, Groups, Businesses and People. JOIN TODAY

Comments (0)
Login or Join to comment.